Is Diebold Nixdorf, (DBD) Stock Outpacing Its Business Services Peers This Year?

DBD

Investors focused on the Business Services space have likely heard of Diebold Nixdorf, (DBD - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Business Services sector should help us answer this question.

Diebold Nixdorf, is one of 191 companies in the Business Services group. The Business Services group currently sits at #13 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. DBD is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for DBD's full-year earnings has moved 319.51% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Based on the latest available data, DBD has gained about 323.29% so far this year. In comparison, Business Services companies have returned an average of 19.45%. As we can see, Diebold Nixdorf, is performing better than its sector in the calendar year.

Breaking things down more, DBD is a member of the Financial Transaction Services industry, which includes 23 individual companies and currently sits at #177 in the Zacks Industry Rank. This group has gained an average of 20.74% so far this year, so DBD is performing better in this area.

Investors in the Business Services sector will want to keep a close eye on DBD as it attempts to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>